GeoVax Labs, Inc. (GOVX)
2.98
+0.19
(+6.81%)
USD |
NASDAQ |
Jan 21, 16:00
3.00
+0.02
(+0.67%)
Pre-Market: 09:26
GeoVax Labs Free Cash Flow: -24.29M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Omeros Corp. | -105.32M |
| Vistagen Therapeutics, Inc. | -53.96M |
| Daré Bioscience, Inc. | -17.15M |
| Spero Therapeutics, Inc. | -27.67M |
| Hyperion DeFi, Inc. | -16.82M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.212M |
| Cash from Financing (Quarterly) | 8.127M |
| Free Cash Flow Per Share (Quarterly) | -7.655 |
| Free Cash Flow to Equity (Quarterly) | -6.212M |
| Free Cash Flow to Firm (Quarterly) | -6.212M |
| Free Cash Flow Yield | -236.3% |